Home
Clinical Trials
Systemic Redesign and Demonst...

Systemic Redesign and Demonstration for Early Detection, Evaluation and Management of Chronic Kidney Disease in Shanghai

Last Updated: 2017-03-24

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

2000000 participants

Study Classification

OBSERVATIONAL

Study Start Date

2015-10-01

Study Completion Date

2018-06-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Based on clinical evidence based medicine and organizational management model, investigators redesign the prevention and treatment of chronic kidney disease of public health system in Shanghai China. The investigators hope to find early chronic kidney disease, prevention and clinical intervention of orderly combination. The advantages of this system were confirmed by comparing the prevalence rate, awareness rate and treatment rate before and after the completion of the system.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Construction of Symptom Network in Maintenance Hemodialysis Patients

NCT05837988

Symptom Cluster Symptoms and Signs Hemodialysis Complication +1 more

NOT_YET_RECRUITING

A Retrospective Observational Study to Describe Anaemia Management, Burden of Disease and Outcomes in Chinese Patients on Peritoneal Dialysis Using a Clinical Database

NCT04948424

Anemia

COMPLETED

Survey and Reduction of Mortality in Peridialysis Uremic Patients Via Intervention of Risk Factors

NCT04088526

End Stage Renal Disease on Dialysis

UNKNOWN NA

A Multi-center Prospective Cohort Study Based on Peritoneal Dialysis Telemedicine-assisted Platform

NCT03571451

Peritoneal Dialysis

RECRUITING

Survival on Peritoneal Dialysis (PD) Versus Hemodialysis (HD) in China

NCT01413074

End Stage Renal Disease

TERMINATED PHASE4

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The whole study mainly includes the following parts:

1. Establishment of a database of patients with kidney disease, and training data entry specialist in every center.
2. Conduct propaganda of kidney disease knowledge, training professional doctors in center hospital and community hospital.
3. Search for high-risk patients, and screening for patients with kidney disease from community residents in community hospital.
4. Establishment of a standardized and orderly patient referral process from community hospital to center hospital or three level of first-class hospital.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Chronic Kidney Diseases

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

chronic kidney disease patients group

These patients were screened from 2000000 of the population. The investigator will compare the prevalence rate, awareness rate and treatment rate before and after the completion of the system. The degree of decreased glomerular filtration rate is also an important evaluation index.

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Over 18 years of age.
* Signed informed consent

Exclusion Criteria

* Refused to accept the blood and urine test

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Changlin Mei

Professor, Director of kidney Institute of the people's Liberation Army

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Changlin Mei, Master

Role: PRINCIPAL_INVESTIGATOR

Shanghai Changzheng Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.